ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Leishmaniasis Treatment Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-31E2739
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Leishmaniasis Treatment Market Insights Forecast to 2028
BUY CHAPTERS

Global Leishmaniasis Treatment Market Insights, Forecast to 2030

Code: QYRE-Auto-31E2739
Report
December 2024
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
iCo Therapeutics
Aeterna Zentaris
AEterna Zentaris AG
Pieris Pharmaceuticals
Dafra Pharma
Eurofins
Eurofins Advinus

Leishmaniasis Treatment Market Size

The global Leishmaniasis Treatment market is projected to grow from US$ 102.9 million in 2024 to US$ 137.9 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.0% during the forecast period.

Leishmaniasis Treatment Market

Leishmaniasis Treatment Market

A drug used to treat diseases caused by parasitic protozoa leishmania
Market Analysis and Insights: Global Leishmaniasis Treatment Market
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Leishmaniasis Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Leishmaniasis Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Leishmaniasis Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Leishmaniasis Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Leishmaniasis Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Leishmaniasis Treatment revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Leishmaniasis Treatment Market Report

Report Metric Details
Report Name Leishmaniasis Treatment Market
Accounted market size in 2024 US$ 102.9 million
Forecasted market size in 2030 US$ 137.9 million
Base Year 2024
Forecasted years 2025 - 2030
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck, iCo Therapeutics, AEterna Zentaris, AEterna Zentaris AG, Eurofins Advinus, Pieris Pharmaceuticals, Dafra Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Leishmaniasis Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Leishmaniasis Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Leishmaniasis Treatment revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

What is the Leishmaniasis Treatment Market size in 2030?

Ans: The Leishmaniasis Treatment Market size in 2030 will be US$ 137.9 million.

Who are the main players in the Leishmaniasis Treatment Market report?

Ans: The main players in the Leishmaniasis Treatment Market are Merck, iCo Therapeutics, AEterna Zentaris, AEterna Zentaris AG, Eurofins Advinus, Pieris Pharmaceuticals, Dafra Pharma

What are the Application segmentation covered in the Leishmaniasis Treatment Market report?

Ans: The Applications covered in the Leishmaniasis Treatment Market report are Visceral Leishmaniasis, Cutaneous Leishmaniasis

What are the Type segmentation covered in the Leishmaniasis Treatment Market report?

Ans: The Types covered in the Leishmaniasis Treatment Market report are Meglumine Antimoniate, Pentamidine, Hydroxyl Amidine Stilbene, Amphotericin B

Recommended Reports

Parasitic Disease Therapies

Drug Delivery & Manufacturing

Chronic & Infectious Diseases

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Leishmaniasis Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Meglumine Antimoniate
1.2.3 Pentamidine
1.2.4 Hydroxyl Amidine Stilbene
1.2.5 Amphotericin B
1.3 Market by Application
1.3.1 Global Leishmaniasis Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Visceral Leishmaniasis
1.3.3 Cutaneous Leishmaniasis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Leishmaniasis Treatment Market Perspective (2019-2030)
2.2 Global Leishmaniasis Treatment Growth Trends by Region
2.2.1 Leishmaniasis Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Leishmaniasis Treatment Historic Market Size by Region (2019-2024)
2.2.3 Leishmaniasis Treatment Forecasted Market Size by Region (2025-2030)
2.3 Leishmaniasis Treatment Market Dynamics
2.3.1 Leishmaniasis Treatment Industry Trends
2.3.2 Leishmaniasis Treatment Market Drivers
2.3.3 Leishmaniasis Treatment Market Challenges
2.3.4 Leishmaniasis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Leishmaniasis Treatment by Players
3.1.1 Global Leishmaniasis Treatment Revenue by Players (2019-2024)
3.1.2 Global Leishmaniasis Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Leishmaniasis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Leishmaniasis Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Leishmaniasis Treatment Market Concentration Ratio
3.4.1 Global Leishmaniasis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Leishmaniasis Treatment Revenue in 2023
3.5 Global Key Players of Leishmaniasis Treatment Head office and Area Served
3.6 Global Key Players of Leishmaniasis Treatment, Product and Application
3.7 Global Key Players of Leishmaniasis Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Leishmaniasis Treatment Breakdown Data by Type
4.1 Global Leishmaniasis Treatment Historic Market Size by Type (2019-2024)
4.2 Global Leishmaniasis Treatment Forecasted Market Size by Type (2025-2030)
5 Leishmaniasis Treatment Breakdown Data by Application
5.1 Global Leishmaniasis Treatment Historic Market Size by Application (2019-2024)
5.2 Global Leishmaniasis Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Leishmaniasis Treatment Market Size (2019-2030)
6.2 North America Leishmaniasis Treatment Market Size by Type
6.2.1 North America Leishmaniasis Treatment Market Size by Type (2019-2024)
6.2.2 North America Leishmaniasis Treatment Market Size by Type (2025-2030)
6.2.3 North America Leishmaniasis Treatment Market Share by Type (2019-2030)
6.3 North America Leishmaniasis Treatment Market Size by Application
6.3.1 North America Leishmaniasis Treatment Market Size by Application (2019-2024)
6.3.2 North America Leishmaniasis Treatment Market Size by Application (2025-2030)
6.3.3 North America Leishmaniasis Treatment Market Share by Application (2019-2030)
6.4 North America Leishmaniasis Treatment Market Size by Country
6.4.1 North America Leishmaniasis Treatment Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Leishmaniasis Treatment Market Size by Country (2019-2024)
6.4.3 North America Leishmaniasis Treatment Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Leishmaniasis Treatment Market Size (2019-2030)
7.2 Europe Leishmaniasis Treatment Market Size by Type
7.2.1 Europe Leishmaniasis Treatment Market Size by Type (2019-2024)
7.2.2 Europe Leishmaniasis Treatment Market Size by Type (2025-2030)
7.2.3 Europe Leishmaniasis Treatment Market Share by Type (2019-2030)
7.3 Europe Leishmaniasis Treatment Market Size by Application
7.3.1 Europe Leishmaniasis Treatment Market Size by Application (2019-2024)
7.3.2 Europe Leishmaniasis Treatment Market Size by Application (2025-2030)
7.3.3 Europe Leishmaniasis Treatment Market Share by Application (2019-2030)
7.4 Europe Leishmaniasis Treatment Market Size by Country
7.4.1 Europe Leishmaniasis Treatment Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Leishmaniasis Treatment Market Size by Country (2019-2024)
7.4.3 Europe Leishmaniasis Treatment Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Leishmaniasis Treatment Market Size (2019-2030)
8.2 China Leishmaniasis Treatment Market Size by Type
8.2.1 China Leishmaniasis Treatment Market Size by Type (2019-2024)
8.2.2 China Leishmaniasis Treatment Market Size by Type (2025-2030)
8.2.3 China Leishmaniasis Treatment Market Share by Type (2019-2030)
8.3 China Leishmaniasis Treatment Market Size by Application
8.3.1 China Leishmaniasis Treatment Market Size by Application (2019-2024)
8.3.2 China Leishmaniasis Treatment Market Size by Application (2025-2030)
8.3.3 China Leishmaniasis Treatment Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Leishmaniasis Treatment Market Size (2019-2030)
9.2 Asia Leishmaniasis Treatment Market Size by Type
9.2.1 Asia Leishmaniasis Treatment Market Size by Type (2019-2024)
9.2.2 Asia Leishmaniasis Treatment Market Size by Type (2025-2030)
9.2.3 Asia Leishmaniasis Treatment Market Share by Type (2019-2030)
9.3 Asia Leishmaniasis Treatment Market Size by Application
9.3.1 Asia Leishmaniasis Treatment Market Size by Application (2019-2024)
9.3.2 Asia Leishmaniasis Treatment Market Size by Application (2025-2030)
9.3.3 Asia Leishmaniasis Treatment Market Share by Application (2019-2030)
9.4 Asia Leishmaniasis Treatment Market Size by Region
9.4.1 Asia Leishmaniasis Treatment Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Leishmaniasis Treatment Market Size by Region (2019-2024)
9.4.3 Asia Leishmaniasis Treatment Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Leishmaniasis Treatment Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Leishmaniasis Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Leishmaniasis Treatment Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Leishmaniasis Treatment Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Leishmaniasis Treatment Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Leishmaniasis Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Leishmaniasis Treatment Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Leishmaniasis Treatment Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Leishmaniasis Treatment Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Leishmaniasis Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Leishmaniasis Treatment Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Leishmaniasis Treatment Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Leishmaniasis Treatment Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Leishmaniasis Treatment Introduction
11.1.4 Merck Revenue in Leishmaniasis Treatment Business (2019-2024)
11.1.5 Merck Recent Developments
11.2 iCo Therapeutics
11.2.1 iCo Therapeutics Company Details
11.2.2 iCo Therapeutics Business Overview
11.2.3 iCo Therapeutics Leishmaniasis Treatment Introduction
11.2.4 iCo Therapeutics Revenue in Leishmaniasis Treatment Business (2019-2024)
11.2.5 iCo Therapeutics Recent Developments
11.3 AEterna Zentaris
11.3.1 AEterna Zentaris Company Details
11.3.2 AEterna Zentaris Business Overview
11.3.3 AEterna Zentaris Leishmaniasis Treatment Introduction
11.3.4 AEterna Zentaris Revenue in Leishmaniasis Treatment Business (2019-2024)
11.3.5 AEterna Zentaris Recent Developments
11.4 AEterna Zentaris AG
11.4.1 AEterna Zentaris AG Company Details
11.4.2 AEterna Zentaris AG Business Overview
11.4.3 AEterna Zentaris AG Leishmaniasis Treatment Introduction
11.4.4 AEterna Zentaris AG Revenue in Leishmaniasis Treatment Business (2019-2024)
11.4.5 AEterna Zentaris AG Recent Developments
11.5 Eurofins Advinus
11.5.1 Eurofins Advinus Company Details
11.5.2 Eurofins Advinus Business Overview
11.5.3 Eurofins Advinus Leishmaniasis Treatment Introduction
11.5.4 Eurofins Advinus Revenue in Leishmaniasis Treatment Business (2019-2024)
11.5.5 Eurofins Advinus Recent Developments
11.6 Pieris Pharmaceuticals
11.6.1 Pieris Pharmaceuticals Company Details
11.6.2 Pieris Pharmaceuticals Business Overview
11.6.3 Pieris Pharmaceuticals Leishmaniasis Treatment Introduction
11.6.4 Pieris Pharmaceuticals Revenue in Leishmaniasis Treatment Business (2019-2024)
11.6.5 Pieris Pharmaceuticals Recent Developments
11.7 Dafra Pharma
11.7.1 Dafra Pharma Company Details
11.7.2 Dafra Pharma Business Overview
11.7.3 Dafra Pharma Leishmaniasis Treatment Introduction
11.7.4 Dafra Pharma Revenue in Leishmaniasis Treatment Business (2019-2024)
11.7.5 Dafra Pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Merck
iCo Therapeutics
Aeterna Zentaris
AEterna Zentaris AG
Pieris Pharmaceuticals
Dafra Pharma
Eurofins
Eurofins Advinus
List of Tables
    Table 1. Global Leishmaniasis Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Meglumine Antimoniate
    Table 3. Key Players of Pentamidine
    Table 4. Key Players of Hydroxyl Amidine Stilbene
    Table 5. Key Players of Amphotericin B
    Table 6. Global Leishmaniasis Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global Leishmaniasis Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Leishmaniasis Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Leishmaniasis Treatment Market Share by Region (2019-2024)
    Table 10. Global Leishmaniasis Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Leishmaniasis Treatment Market Share by Region (2025-2030)
    Table 12. Leishmaniasis Treatment Market Trends
    Table 13. Leishmaniasis Treatment Market Drivers
    Table 14. Leishmaniasis Treatment Market Challenges
    Table 15. Leishmaniasis Treatment Market Restraints
    Table 16. Global Leishmaniasis Treatment Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Leishmaniasis Treatment Revenue Share by Players (2019-2024)
    Table 18. Global Top Leishmaniasis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leishmaniasis Treatment as of 2023)
    Table 19. Global Leishmaniasis Treatment Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by Leishmaniasis Treatment Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of Leishmaniasis Treatment, Headquarters and Area Served
    Table 22. Global Key Players of Leishmaniasis Treatment, Product and Application
    Table 23. Global Key Players of Leishmaniasis Treatment, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Leishmaniasis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Leishmaniasis Treatment Revenue Market Share by Type (2019-2024)
    Table 27. Global Leishmaniasis Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Leishmaniasis Treatment Revenue Market Share by Type (2025-2030)
    Table 29. Global Leishmaniasis Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Leishmaniasis Treatment Revenue Share by Application (2019-2024)
    Table 31. Global Leishmaniasis Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Leishmaniasis Treatment Revenue Share by Application (2025-2030)
    Table 33. North America Leishmaniasis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America Leishmaniasis Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America Leishmaniasis Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 36. North America Leishmaniasis Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 37. North America Leishmaniasis Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Leishmaniasis Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Leishmaniasis Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Leishmaniasis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe Leishmaniasis Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe Leishmaniasis Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 43. Europe Leishmaniasis Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 44. Europe Leishmaniasis Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe Leishmaniasis Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe Leishmaniasis Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China Leishmaniasis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China Leishmaniasis Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China Leishmaniasis Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 50. China Leishmaniasis Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 51. Asia Leishmaniasis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia Leishmaniasis Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia Leishmaniasis Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 54. Asia Leishmaniasis Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Leishmaniasis Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia Leishmaniasis Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia Leishmaniasis Treatment Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Leishmaniasis Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Leishmaniasis Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Leishmaniasis Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Leishmaniasis Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Leishmaniasis Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America Leishmaniasis Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Leishmaniasis Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 65. Merck Company Details
    Table 66. Merck Business Overview
    Table 67. Merck Leishmaniasis Treatment Product
    Table 68. Merck Revenue in Leishmaniasis Treatment Business (2019-2024) & (US$ Million)
    Table 69. Merck Recent Developments
    Table 70. iCo Therapeutics Company Details
    Table 71. iCo Therapeutics Business Overview
    Table 72. iCo Therapeutics Leishmaniasis Treatment Product
    Table 73. iCo Therapeutics Revenue in Leishmaniasis Treatment Business (2019-2024) & (US$ Million)
    Table 74. iCo Therapeutics Recent Developments
    Table 75. AEterna Zentaris Company Details
    Table 76. AEterna Zentaris Business Overview
    Table 77. AEterna Zentaris Leishmaniasis Treatment Product
    Table 78. AEterna Zentaris Revenue in Leishmaniasis Treatment Business (2019-2024) & (US$ Million)
    Table 79. AEterna Zentaris Recent Developments
    Table 80. AEterna Zentaris AG Company Details
    Table 81. AEterna Zentaris AG Business Overview
    Table 82. AEterna Zentaris AG Leishmaniasis Treatment Product
    Table 83. AEterna Zentaris AG Revenue in Leishmaniasis Treatment Business (2019-2024) & (US$ Million)
    Table 84. AEterna Zentaris AG Recent Developments
    Table 85. Eurofins Advinus Company Details
    Table 86. Eurofins Advinus Business Overview
    Table 87. Eurofins Advinus Leishmaniasis Treatment Product
    Table 88. Eurofins Advinus Revenue in Leishmaniasis Treatment Business (2019-2024) & (US$ Million)
    Table 89. Eurofins Advinus Recent Developments
    Table 90. Pieris Pharmaceuticals Company Details
    Table 91. Pieris Pharmaceuticals Business Overview
    Table 92. Pieris Pharmaceuticals Leishmaniasis Treatment Product
    Table 93. Pieris Pharmaceuticals Revenue in Leishmaniasis Treatment Business (2019-2024) & (US$ Million)
    Table 94. Pieris Pharmaceuticals Recent Developments
    Table 95. Dafra Pharma Company Details
    Table 96. Dafra Pharma Business Overview
    Table 97. Dafra Pharma Leishmaniasis Treatment Product
    Table 98. Dafra Pharma Revenue in Leishmaniasis Treatment Business (2019-2024) & (US$ Million)
    Table 99. Dafra Pharma Recent Developments
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Leishmaniasis Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Leishmaniasis Treatment Market Share by Type: 2023 VS 2030
    Figure 3. Meglumine Antimoniate Features
    Figure 4. Pentamidine Features
    Figure 5. Hydroxyl Amidine Stilbene Features
    Figure 6. Amphotericin B Features
    Figure 7. Global Leishmaniasis Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Leishmaniasis Treatment Market Share by Application: 2023 VS 2030
    Figure 9. Visceral Leishmaniasis Case Studies
    Figure 10. Cutaneous Leishmaniasis Case Studies
    Figure 11. Leishmaniasis Treatment Report Years Considered
    Figure 12. Global Leishmaniasis Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Leishmaniasis Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Leishmaniasis Treatment Market Share by Region: 2023 VS 2030
    Figure 15. Global Leishmaniasis Treatment Market Share by Players in 2023
    Figure 16. Global Top Leishmaniasis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leishmaniasis Treatment as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Leishmaniasis Treatment Revenue in 2023
    Figure 18. North America Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Leishmaniasis Treatment Market Share by Type (2019-2030)
    Figure 20. North America Leishmaniasis Treatment Market Share by Application (2019-2030)
    Figure 21. North America Leishmaniasis Treatment Market Share by Country (2019-2030)
    Figure 22. United States Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Leishmaniasis Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 25. Europe Leishmaniasis Treatment Market Share by Type (2019-2030)
    Figure 26. Europe Leishmaniasis Treatment Market Share by Application (2019-2030)
    Figure 27. Europe Leishmaniasis Treatment Market Share by Country (2019-2030)
    Figure 28. Germany Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. China Leishmaniasis Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 35. China Leishmaniasis Treatment Market Share by Type (2019-2030)
    Figure 36. China Leishmaniasis Treatment Market Share by Application (2019-2030)
    Figure 37. Asia Leishmaniasis Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. Asia Leishmaniasis Treatment Market Share by Type (2019-2030)
    Figure 39. Asia Leishmaniasis Treatment Market Share by Application (2019-2030)
    Figure 40. Asia Leishmaniasis Treatment Market Share by Region (2019-2030)
    Figure 41. Japan Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. South Korea Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. China Taiwan Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. India Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Australia Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Leishmaniasis Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Leishmaniasis Treatment Market Share by Type (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Leishmaniasis Treatment Market Share by Application (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Leishmaniasis Treatment Market Share by Country (2019-2030)
    Figure 51. Brazil Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Mexico Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Turkey Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Israel Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. GCC Countries Leishmaniasis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Merck Revenue Growth Rate in Leishmaniasis Treatment Business (2019-2024)
    Figure 58. iCo Therapeutics Revenue Growth Rate in Leishmaniasis Treatment Business (2019-2024)
    Figure 59. AEterna Zentaris Revenue Growth Rate in Leishmaniasis Treatment Business (2019-2024)
    Figure 60. AEterna Zentaris AG Revenue Growth Rate in Leishmaniasis Treatment Business (2019-2024)
    Figure 61. Eurofins Advinus Revenue Growth Rate in Leishmaniasis Treatment Business (2019-2024)
    Figure 62. Pieris Pharmaceuticals Revenue Growth Rate in Leishmaniasis Treatment Business (2019-2024)
    Figure 63. Dafra Pharma Revenue Growth Rate in Leishmaniasis Treatment Business (2019-2024)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Systemic Lupus Erythematosus Treatment Market Insights Forecast to 2030
Global Rheumatic Disorders Drug Market Insights Forecast to 2030
Global Staphylococcal Infection Treatment Market Insights Forecast to 2030
Global Photodynamic Therapy Market Insights Forecast to 2030
Global Parasitic Diseases Therapeutic Market Insights Forecast to 2030
Global Metabolic Disorder Therapeutics Market Insights Forecast to 2030
Global Osteoporosis Treatment Market Insights Forecast to 2030
Global Chronic Obstructive Pulmonary Disease COPD Treatment Market Insights Forecast to 2030
Global Systemic Inflammatory Response Syndrome Treatment Market Insights Forecast to 2030
Global Angioedema Treatment Market Insights Forecast to 2030
Global Diabetic Neurological Disorder Therapeutic Drug Market Insights Forecast to 2030
Global Burn Therapy Market Insights Forecast to 2030
Global Pseudomonas Aeruginosa Infection Treatment Market Insights Forecast to 2030
Global Atherosclerosis Drugs Market Insights Forecast to 2030
Global Drug Delivery in Cancer Market Insights Forecast to 2030
Global Blood Pressure Disorders Drug Market Insights Forecast to 2030
Global Burn Treatment Management Market Insights Forecast to 2030
Global Metastatic Colorectal Cancer Drug Market Insights Forecast to 2030
Global Insect Control Products Market Insights Forecast to 2030
Global Cryotherapy Market Insights Forecast to 2030

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions